Computer-aided detection (CAD) developer Medicsight has received medical device licenses from the Therapeutic Products Directorate (TPD) of Health Canada.
As a result, the London-based firm can now begin marketing and selling its ColonCAD API and LungCAD API in Canada.
By AuntMinnie.com staff writers
February 14, 2007
Related Reading
Medicsight changes name to MGT Capital Investments, January 29, 2007
Medicsight to partner with 3mensio, November 29, 2006
FDA clears Medicsight ColonCAR software, November 27, 2006
Medicsight opens NYC office, November 6, 2006
Road to RSNA, Medicsight, November 3, 2006
Copyright © 2007 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
